(Q43674745)

25 November 2017

title

Interferon-alpha plus amantadine in chronic hepatitis C resistant to interferon alone: a pilot randomized study (English)

1 reference

25 November 2017

1 reference

Gaeta GB

1

1 reference

25 November 2017

Stornaiuolo G

2

1 reference

25 November 2017

Stanzione M

3

1 reference

25 November 2017

Ascione T

4

1 reference

25 November 2017

Pasquazzi C

5

1 reference

25 November 2017

Taliani G

6

1 reference

25 November 2017

Cimino L

7

1 reference

25 November 2017

Budillon G

8

1 reference

25 November 2017

Piccinino F

9

1 reference

25 November 2017

publication date

1 July 2001

1 reference

Journal of Viral Hepatitis

25 November 2017

published in

1 reference

25 November 2017

volume

8

1 reference

25 November 2017

issue

4

1 reference

25 November 2017

page(s)

284-286

1 reference

Evaluation of efficacy of antiviral therapy for chronic hepatitis C: a EUROHEP Consensus Report on response criteria

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00298.X

Efficacy of a second cycle of interferon therapy in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00298.X

Human leucocyte interferon-alpha in chronic hepatitis C resistant to recombinant or lymphoblastoid interferon-alpha: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00298.X

A pilot study of rimantadine for patients with chronic hepatitis C unresponsive to interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00298.X

Combination antiviral therapy for respiratory virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00298.X

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00298.X

Classification of chronic viral hepatitis: a need for reassessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00298.X

Ribavirin treatment for chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00298.X

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00298.X

Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00298.X

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00298.X

10.1046/J.1365-2893.2001.00298.X

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference